Latest Breaking News On - Md duke university school of medicine - Page 1 : comparemela.com

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

In Bridge-TIMI 73a and SHASTA-2, the RNA-silencing therapies cut triglycerides quickly, offering hope for hard-to-treat patients.

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

Hospital at Home Strategy Could Disrupt 'Low-Value' Care for Worsening HF

While the concept has potential, more research is needed on implementation and patient selection, says Mitchell Psotka.

Corbus Pharmaceuticals Hosting Virtual 'Meet the Expert' Series: Blocking TGFβ with CRB-601--a New Play for an Old Target

First in the series to occur on Tuesday, April 25, 2023 at 11:00 AM ET NORWOOD, Mass., April 18, 2023 /PRNewswire/ Corbus Pharmaceuticals Holdings, Inc. , a precision oncology company, today. | April 18, 2023